Market Research Insights

San Francisco, 23 July 2019:   The Report   Nanocapsules Market   Analysis By Application (Healthcare, Food & Nutraceuticals, Cosmetics, Agricultural Production, Others); By Therapy Area (Oncology, Pain Management, Endocrinology, Others), And Segment Forecasts, 2018 – 2025 The global nanocapsules market is expected to reach a value of USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc. Nanocapsules deliver bio active molecules by targeted delivery and is finds application in various industries such as healthcare, genetic engineering, food science and agriculture, cosmetics, agrochemicals, cleansing products, among others. The wide usage of these products across several industries promises lucrative opportunities for the development and commercialization of novel and improved therapies and solutions. Nanocapsules’ life science applications rely on the ability to achieve controlled and effective release of nano-sized drug carriers to targeted zones. N

San Francisco, 23 July 2019:   The Report   Biosimilars Market   Size, Share & Trends Analysis Report By Product, By Application (Oncology, Growth Hormone, Blood Disorders, Chronic & Autoimmune Disorders), By Region, And Segment Forecasts, 2018 – 2025 The global biosimilars market size is expected to reach a value of USD 61.47 billion by 2025, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 34.2% over the forecast period. Major biological drugs are approaching the patent cliff. This is the most significant driving factor for the market. For instance, Roche’s MabThera/Rituxan (rituximab), a monoclonal antibody biologics was approved by the U.S. Food and Drug Administration (FDA) in November 1997 and its U.S. patent expired in September 2016. Several companies such as Amgen, Boehringer Ingelheim, and Pfizer are focusing on development of biosimilar drug of rituximab. Furthermore, lower cost of biosimilars compared to patented biol

San Francisco, 23 July 2019:   The Report   Live Cell Imaging Market   Analysis By Product, Application, Technology (Time lapse Microscopy, Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening), & Segment Forecasts, 2018 – 2025 The global live cell imaging market is expected to reach USD 9.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. Understanding the cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market. In a survey by Drug Discovery World Spring, almost 21% researchers prefer & use live cell imaging and 31% plan to use it i

San Francisco, 23 July 2019:   The Report   Microelectronic Medical Implants Market   Analysis Report by Product (Pacemakers & Defibrillators, Neurostimulators, Implantable Drug Pumps, Spinal Fusion Stimulators), by Technology, And Segment Forecasts, 2018 – 2025 The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.8% CAGR during the forecast period. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth. Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these

San Francisco, 23 July 2019:   The Report   Orthopedic Bone Cement Market  Analysis By End-use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2025 The global orthopedic bone cement market is expected to reach USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Growing number of orthopedic surgeries is one of the key factors expected to drive revenue growth in coming few years. Orthopedic bone cement helps support and anchor artificial joints and fractured bones. It works by filling the empty space between the bone and an implant, which anchors the joint. This in turn provides stability and elasticity to the joints. Bone cement was introduced in 1940s and has been widely used by physicians since then. The increasing number of orthopedic surgeries globally is expected to boost demand for the cement in near future. As per Australian Society of O

San Francisco, 23 July 2019:   The Report   Veterinary Services Market   Analysis Report By Animal Type (Production (Poultry, Cattle, Swine), Companion (Cats, Dogs, Equine)), By Region (APAC, North America, Europe), And Segment Forecasts, 2018 – 2025 The global veterinary services market size is expected to reach USD 142.04 billion by 2025, according to a new report by Grand View Research, Inc., experiencing a CAGR of 5.6% during the forecast period. Rising concerns regarding food security and safety are encouraging adoption of veterinary services worldwide. In addition, increasing pet adoption is one of the primary growth stimulants for the market. In addition, advent of risk-based management systems, designed to analyze real-time fluctuations in food-borne and zoonotic disease prevalence, is widening the scope for growth of veterinary services market. Veterinary services play a critical role in risk aversion and facilitates implementation of various guidelines issued by regulato

San Francisco, 23 July 2019:   The Report   Sickle Cell Disease Treatment Market   Size, Share & Trends Analysis Report By Treatment Type (Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant), By Major Markets, Vendor Landscape, And Segment Forecasts, 2018 – 2023 The global sickle cell disease treatment market size is expected to reach USD 5.5 billion by 2023, according to a new report by Grand View Research, Inc., exhibiting a 14.3% CAGR during the forecast period. Several factors such as increase in investments for R&D, growing target population, and favorable government initiatives are anticipated to drive the market. Currently available treatments for sickle cell disease (SCD) usually provide symptomatic relief and palliative care. These treatment methods generally include blood transfusions, bone marrow transplant, and pharmacotherapy. Although bone marrow transplant is the only potentially curative treatment, it is recommended only to a small percentage of pat